共 121 条
[31]
Raschke R(2001)Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (reviparin): results of a randomized controlled trial Arthroscopy 17 393-7
[32]
Weitz JI(1997)Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. The COLUMBUS Investigators New Engl J Med 337 657-58
[33]
Andrassy K(2001)Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis N Engl J Med 344 626-73
[34]
Eschenfelder V(1977)Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy J Lab Clin Med 89 1018-10L
[35]
Koderisch J(1993)Dose-finding studies of reviparin in elective hip surgery Semin Thromb Hemost 1 44-7
[36]
Desnoyers P-C(2000)A randomized control trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial [abstract no. 2116] Blood 96 492-81
[37]
Samama M-M(1998)Prevention of thromboembolism with low-molecular-weight heparin in operated and non-operated surgical and orthopaedic outpatients [in German] Zentralbl Chir 123 1284-9
[38]
Abildgarrd U(1998)Low-molecular-weight heparin for the treatment of deep vein thrombosis Pharmacotherapy 18 748-74
[39]
Broze GJ(1998)Thrombolytic therapy for venous thrombosis and pulmonary embolism Baillieres Clin Haematol 11 663-23
[40]
Azizi M(1998)Low-molecular-weight heparins: Pharmacologic profile and product differentiation Am J Cardiol 82 3L-60